Tune in to this 45 minute conversation as Andy Jackson and Kevin Bittman explore how autoantibodies have empowered biomarker research and discover:
- How the field has changed over the years
- The benefits of a novel approach to detection
- How autoantibodies can be used to stratify patients and predict treatment response
The Immune System has something to say. Are you listening?
The humoral immune system responds quickly and specifically to aberrant proteins produced throughout the disease process, effectively marking a disease, often well before symptoms occur. Autoantibodies are these markers. Orthogonal to other ‘omics methods, autoantibodies are highly specific, abundant and stable. Because they are a specific read out of disease, and not just a snap-shot of the physiological state, they are highly biologically relevant biomarkers.